Answers are grounded in this paper and cite their sources.
The AECT is the first tool to assess disease control in recurrent AE patients. Its retrospective approach, its brevity and its simple scoring make the AECT ideally suited for clinical practice and trials. Its validity and reliability need to be determined in future independent studies.
No takes yet. Share an insight, caveat, or question.
Weller et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: